EU’s EMA Plans to Open Up Proprietary Drug Trial Data to Outside Investigators
European Medicines Agency (EMA) -- the European drug regulator -- "is opening its data vaults to systematic scrutiny in a move that will let independent researchers trawl through millions of pages...
“We do things at Pfizer that are best for shareholders of Pfizer.” You Gotta...
I can't believe a Pfizer "spokesperson" (Corporate Secretary and Chief Governance Counsel, Matthew Lepore) said:
“We do things at Pfizer that are best for shareholders of Pfizer"
when defending Pfizer's continued financial support...
Gamification’s Brave New World Circa 1984: Operation Frog
There's a lot of brouhaha these days in pharma circles about "gamification" as if it were the newest thing since sliced bread. What is "gamification," you ask? According to the Gamification.org...
Can Pharma Cure Alzheimer’s Disease? A Pfizer Pre-Launch Multichannel Marketing Case Study
Last month I quipped on this blog that "Pfizer's Social Media Initiatives are Getting Old." Actually, that was a review of Pfizer's new "Get Old" initiative, which Pfizer says is a...
Multichannel Marketing: Easy to Brag About, but Difficult to Do
"Multichannel pharma marketing is conceptually relatively simple to understand, but incredibly difficult in practice," says Len Starnes, former Head of Digital Marketing & Sales, General Medicine at Bayer Schering Pharma....
Are Pinterest Women & Virality Worth It to Pharma Marketers?
Once again I am responding to a Pharmaforum guest blogger post that was promoted by the author (Kelley Connors) on Twitter: "How Pinterest Creates the Love for #Healthcare #Marketers #hcsm #pharma...
Blaming the FDA for Pharma’s Tepid Use of Social Media
A tweet by Paul Tunnah (@pharmaphorum) caught my attention this morning:
"…the FDA social media regulations for pharma marketing are extremely strict…" bit.ly/NaPU7h #pharma #socialmedia
This linked to a blog post "Social media...
The 3rd Annual Pharmaguy Social Media Pioneer Award
If you are a regular reader of Pharma Marketing Blog, you know that I generally do not like awards sponsored by pharma trade publications (see “Awards. What Are They Good For?”)....
Positive or Not, Pediatric Drug Trials Pay Off: Cymbalta and Oxycontin Case Studies
Very few people may know that drug companies can get an additional six months of market exclusivity from FDA as an inducement for them to study the efficacy and safety of...
Pfizer’s Centrum Will No Longer Claim It Aids “Breast Health” and “Colon Health”
As reported by Reuters (here) "Pfizer, bowing to allegations of deceptive advertising lodged by a consumer watchdog group, has agreed to drop 'breast health' and 'colon health' claims from the labels...
